Infusive Asset Management Inc. cut its stake in The Procter & Gamble Company (NYSE:PG - Free Report) by 13.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 59,627 shares of the company's stock after selling 9,493 shares during the quarter. Procter & Gamble comprises about 4.5% of Infusive Asset Management Inc.'s investment portfolio, making the stock its 7th biggest position. Infusive Asset Management Inc.'s holdings in Procter & Gamble were worth $9,996,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently modified their holdings of PG. NewSquare Capital LLC grew its stake in shares of Procter & Gamble by 933.3% during the fourth quarter. NewSquare Capital LLC now owns 155 shares of the company's stock valued at $26,000 after acquiring an additional 140 shares in the last quarter. Hoey Investments Inc. increased its stake in shares of Procter & Gamble by 321.7% in the fourth quarter. Hoey Investments Inc. now owns 194 shares of the company's stock worth $33,000 after buying an additional 148 shares during the last quarter. LFA Lugano Financial Advisors SA bought a new position in Procter & Gamble during the 4th quarter valued at $34,000. Atlantic Private Wealth LLC increased its position in shares of Procter & Gamble by 95.3% in the 4th quarter. Atlantic Private Wealth LLC now owns 207 shares of the company's stock worth $35,000 after purchasing an additional 101 shares during the last quarter. Finally, Prudent Man Investment Management Inc. bought a new stake in Procter & Gamble in the fourth quarter valued at about $38,000. Institutional investors and hedge funds own 65.77% of the company's stock.
Insiders Place Their Bets
In other Procter & Gamble news, CEO Gary A. Coombe sold 18,000 shares of the stock in a transaction that occurred on Tuesday, February 25th. The stock was sold at an average price of $171.66, for a total transaction of $3,089,880.00. Following the transaction, the chief executive officer now owns 22,051 shares in the company, valued at $3,785,274.66. This trade represents a 44.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Marc S. Pritchard sold 90,450 shares of the firm's stock in a transaction on Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total transaction of $14,819,328.00. Following the completion of the transaction, the insider now owns 172,814 shares in the company, valued at $28,313,845.76. The trade was a 34.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 143,450 shares of company stock valued at $23,988,008 over the last quarter. Insiders own 0.18% of the company's stock.
Analyst Ratings Changes
Several equities research analysts recently issued reports on PG shares. Piper Sandler dropped their price target on Procter & Gamble from $173.00 to $172.00 and set a "neutral" rating on the stock in a research report on Monday, February 24th. Stifel Nicolaus boosted their price objective on shares of Procter & Gamble from $161.00 to $165.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Truist Financial lifted their target price on Procter & Gamble from $180.00 to $185.00 and gave the company a "buy" rating in a research note on Thursday, April 3rd. Barclays restated an "equal weight" rating on shares of Procter & Gamble in a research report on Thursday, March 27th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating for the company in a research report on Friday, April 11th. Seven investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and three have issued a strong buy rating to the company. Based on data from MarketBeat.com, Procter & Gamble currently has an average rating of "Moderate Buy" and an average target price of $181.50.
View Our Latest Analysis on PG
Procter & Gamble Trading Up 1.3 %
Shares of PG stock traded up $2.21 during trading hours on Tuesday, reaching $167.96. 2,837,034 shares of the stock traded hands, compared to its average volume of 8,051,713. The firm has a market capitalization of $393.84 billion, a PE ratio of 26.74, a PEG ratio of 3.76 and a beta of 0.43. The business has a fifty day moving average price of $168.32 and a 200 day moving average price of $168.45. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 1-year low of $156.69 and a 1-year high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.86 by $0.02. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The business had revenue of $21.88 billion during the quarter, compared to analyst estimates of $21.66 billion. During the same period in the prior year, the firm earned $1.84 earnings per share. The firm's revenue was up 2.1% compared to the same quarter last year. On average, equities research analysts forecast that The Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Monday, April 21st will be issued a dividend of $1.0568 per share. This is a positive change from Procter & Gamble's previous quarterly dividend of $1.01. This represents a $4.23 annualized dividend and a yield of 2.52%. The ex-dividend date of this dividend is Monday, April 21st. Procter & Gamble's dividend payout ratio (DPR) is 67.20%.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.